Moderna sues Pfizer and BioNTech for patent infringement on Covid vaccine technology
Moderna said it’s not seeking to have the Pfizer-BioNTech vaccine removed from the market, nor is it seeking an injunction preventing future sales.
Today's Liberal News
By Lauren Gardner
Moderna sues Pfizer and BioNTech for patent infringement on Covid vaccine technology
Moderna said it’s not seeking to have the Pfizer-BioNTech vaccine removed from the market, nor is it seeking an injunction preventing future sales.
Moderna sues Pfizer and BioNTech for patent infringement on Covid vaccine technology
Moderna said it’s not seeking to have the Pfizer-BioNTech vaccine removed from the market, nor is it seeking an injunction preventing future sales.
Moderna sues Pfizer and BioNTech for patent infringement on Covid vaccine technology
Moderna said it’s not seeking to have the Pfizer-BioNTech vaccine removed from the market, nor is it seeking an injunction preventing future sales.
Moderna sues Pfizer and BioNTech for patent infringement on Covid vaccine technology
Moderna said it’s not seeking to have the Pfizer-BioNTech vaccine removed from the market, nor is it seeking an injunction preventing future sales.
Birth control coverage gaps scrutinized as reproductive health landscape shifts
The Biden administration is responding, working to shore up reproductive health policies it can control in the wake of the Supreme Court’s overturning of Roe v. Wade.
Birth control coverage gaps scrutinized as reproductive health landscape shifts
The Biden administration is responding, working to shore up reproductive health policies it can control in the wake of the Supreme Court’s overturning of Roe v. Wade.
Birth control coverage gaps scrutinized as reproductive health landscape shifts
The Biden administration is responding, working to shore up reproductive health policies it can control in the wake of the Supreme Court’s overturning of Roe v. Wade.
Birth control coverage gaps scrutinized as reproductive health landscape shifts
The Biden administration is responding, working to shore up reproductive health policies it can control in the wake of the Supreme Court’s overturning of Roe v. Wade.
Birth control coverage gaps scrutinized as reproductive health landscape shifts
The Biden administration is responding, working to shore up reproductive health policies it can control in the wake of the Supreme Court’s overturning of Roe v. Wade.
Abortion pill maker plans multistate legal action to preserve drug access
The company is currently challenging a Mississippi law that effectively banned telehealth abortions by making patients see doctors in person.
Abortion pill maker plans multistate legal action to preserve drug access
The company is currently challenging a Mississippi law that effectively banned telehealth abortions by making patients see doctors in person.
Abortion pill maker plans multistate legal action to preserve drug access
The company is currently challenging a Mississippi law that effectively banned telehealth abortions by making patients see doctors in person.
FDA advisers recommend strain update to Covid-19 boosters ahead of expected fall surge
The advisory committee signaled a preference for the strain composition to target the BA.4 and BA.5 subvariants.
Abortion pill maker plans multistate legal action to preserve drug access
The company is currently challenging a Mississippi law that effectively banned telehealth abortions by making patients see doctors in person.
FDA advisers recommend strain update to Covid-19 boosters ahead of expected fall surge
The advisory committee signaled a preference for the strain composition to target the BA.4 and BA.5 subvariants.
FDA advisers recommend strain update to Covid-19 boosters ahead of expected fall surge
The advisory committee signaled a preference for the strain composition to target the BA.4 and BA.5 subvariants.
Abortion pill maker plans multistate legal action to preserve drug access
The company is currently challenging a Mississippi law that effectively banned telehealth abortions by making patients see doctors in person.
FDA advisers recommend strain update to Covid-19 boosters ahead of expected fall surge
The advisory committee signaled a preference for the strain composition to target the BA.4 and BA.5 subvariants.
FDA advisers endorse administration of Moderna, Pfizer Covid-19 vaccines in babies, toddlers
The FDA is expected to quickly authorize the vaccines for emergency use.
FDA: Pfizer, Moderna vaccines for kids under 6 are safe, effective
The FDA analyzed the vaccines’ ability to induce neutralizing antibody responses in kids that were comparable to young adults, a concept known as immunobridging. Both met the agency’s success criteria.
FDA advisers vote to recommend Moderna Covid vaccine EUA for kids 6-17
Panel members largely agreed that the benefits of having another vaccine available to these age groups outweigh the potential risks.
FDA: Pfizer, Moderna vaccines for kids under 6 are safe, effective
The FDA analyzed the vaccines’ ability to induce neutralizing antibody responses in kids that were comparable to young adults, a concept known as immunobridging. Both met the agency’s success criteria.
Vaccine injury compensation programs overwhelmed as congressional reform languishes
One program covers nearly three times as many vaccines today as it did when it was created three decades ago. Despite bipartisan calls for change, Congress has failed to act.
Vaccine injury compensation programs overwhelmed as congressional reform languishes
One program covers nearly three times as many vaccines today as it did when it was created three decades ago. Despite bipartisan calls for change, Congress has failed to act.
Vaccine injury compensation programs overwhelmed as congressional reform languishes
One program covers nearly three times as many vaccines today as it did when it was created three decades ago. Despite bipartisan calls for change, Congress has failed to act.
Vaccine injury compensation programs overwhelmed as congressional reform languishes
One program covers nearly three times as many vaccines today as it did when it was created three decades ago. Despite bipartisan calls for change, Congress has failed to act.
Vaccine injury compensation programs overwhelmed as congressional reform languishes
One program covers nearly three times as many vaccines today as it did when it was created three decades ago. Despite bipartisan calls for change, Congress has failed to act.
Vaccine injury compensation programs overwhelmed as congressional reform languishes
One program covers nearly three times as many vaccines today as it did when it was created three decades ago. Despite bipartisan calls for change, Congress has failed to act.
Draft abortion opinion renews urgency on over-the-counter birth control
The push to develop daily oral contraceptives without prescription has been years in the making.